Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

Université Laval

$100,000.00

Drug resistance and drug targets in the protozoan parasite Leishmania

EF 2019-20

Résumé
The discovery of antimicrobial agents was one of the great triumphs of the 20th century. However, we have entered in an era of antimicrobial resistance (AMR), a phenomenon of serious public health concern. Our research program will address this issue. We proposed to understand at the whole genome level how the protozoan parasites becomes resistant. For this we will sequence the whole genome of resistant microorganisms. We will complement these data with a series of chemogenomic screens developed in the laboratory. The data derived from these different approaches will be combined and integrated for generating a complete map of mutations necessary to achieve resistance. The role of these mutations will each be evaluated experimentally. It will also lead to novel drug targets against new promising drug candidates and to novel molecules for the treatment of this neglected tropical diseases affecting more than 12 millions people worldwide.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
407216
Name
Ouellette Marc
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Drug resistance and drug targets in the protozoan parasite Leishmania
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Drug Resistance; Drug Targets; Genomic Screens; Leishmania; Next Generation Sequencing; Parasitologie
Abstract
The discovery of antimicrobial agents was one of the great triumphs of the 20th century. However, we have entered in an era of antimicrobial resistance (AMR), a phenomenon of serious public health concern. Our research program will address this issue. We proposed to understand at the whole genome level how the protozoan parasites becomes resistant. For this we will sequence the whole genome of resistant microorganisms. We will complement these data with a series of chemogenomic screens developed in the laboratory. The data derived from these different approaches will be combined and integrated for generating a complete map of mutations necessary to achieve resistance. The role of these mutations will each be evaluated experimentally. It will also lead to novel drug targets against new promising drug candidates and to novel molecules for the treatment of this neglected tropical diseases affecting more than 12 millions people worldwide.
Competitiondate
201904
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ouellette, Marc
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~